While genomic medicine is a growing area of interest, and genetic and genomic tests are being used more and more widely across UK NHS clinical specialities, challenges relating to governance and regulation of genomic clinical services still exist. Consultant Cliodhna McDonough shares her views on genomic medicine and regulatory issues which require further analysis with Pharma Times.
Click here to read the article.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.